Clinigen Group Share Price (CLIN)
| Bid price | 797.50 | Open price | 803.09 |
|---|---|---|---|
| Ask price | 800.00 | Prev close | 800.00 |
| High price | 808.50 | Spread | 0.31% |
| Low price | 791.50 | Volume | 94,955 |
Register now for FREE live Clinigen Group share prices, Clinigen Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Clinigen Group Level 2 Data, indepth research tools and investor commentary for Clinigen Group (CLIN) and other London Stock Exchange equities.
Clinigen Group Share Price Chart
Register now for FREE Clinigen Group share price charts
Clinigen Group Share Price Information
| Name | Clinigen Group | Epic | CLIN |
|---|---|---|---|
| Sector | Pharmaceuticals & Biotechnology | ISIN | GB00B89J2419 |
| Activites | Clinigen Group plc is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. | Index | n/a |
Clinigen Group Key Numbers
| Latest Share Price (p) | 800.00 | Net Gearing (%) | 42.17 |
|---|---|---|---|
| Market Capitalisation (£m) | 1,076.68 | Gross Gearing (%) | 47.61 |
| Shares in issue (m) | 132.43 | Debt Ratio | 36.83 |
| P/E Ratio | 35.50 | Debt-to-Equity Ratio | 0.64 |
| Total dividends per share (p) | 5.60 | Assets / Equity Ratio | 1.91 |
| Dividend Yield (%) | 0.00 | Price to book value | 3.08 |
| Dividend cover (x) | 4.09 | ROCE (%) | 6.49 |
| Earning per share (p) | 22.90 | EPS Growth (%) | 593.94 |
| 52 week high / low | 1,116.00 / 777.00 | DPS Growth (%) | 12.00 |
Clinigen Group Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 01/10/2018 | PLAC | Shaun Chilton | CEO | 7,101 |
| 01/10/2018 | PLAC | Anne Hyland | NED | 4,142 |
| 24/11/2017 | SELL | Chris Rigg | RES | 4,955 |
| 16/10/2017 | SELL | Shaun Chilton | CEO | 100,000 |
| 03/10/2017 | SELL | John Bacon | RES | 250,000 |
Clinigen Group Company News
Issue of Equity
RNS Number : 1068J Clinigen Group plc 30 November 2018 30 November 2018 Issue of Equity Clinigen Group plc (AIM: CLIN, the "Group") announces that it has made an application for the admission to trading on AIM of 241,594 ordinary shares of 0.1 pence each in the...
Capital Markets Day
RNS Number : 6881I Clinigen Group plc 28 November 2018 28 November 2018 Capital Markets Day Clinigen Group plc (AIM: CLIN, "Clinigen" or the "Group"), the global pharmaceuticals and services company, is holding a Capital Markets Day for institutional investors...
More Clinigen Group Company News >>
Register now for FREE Clinigen Group company news
Clinigen Group Share Price Discussions
Clinigen Group plc (CLIN)
Dealings in Clinigen shares are expected to commence on AIM at 8.00am on Tuesday 25 September 2012, under the ticker symbol CLIN Clinigen is a rapidly-growing specialty pharmaceutical and services company, with one clear aim: to deliver the right drug to the right patient at the right...
Register now for FREE Clinigen Group share price discussions